Eli Lilly & Co. v. Barr Laboratories, Inc.
United States Court of Appeals for the Federal Circuit
251 F.3d 955 (2001)

- Written by Mary Phelan D'Isa, JD
Facts
Eli Lilly & Company (Lilly) (plaintiff) held numerous patents relating to fluoxetine hydrochloride, an active ingredient in its antidepressant Prozac. Lilly alleged that Barr Laboratories, Inc. (Barr) (defendant), the manufacturer of a generic competing antidepressant, infringed one of its patents covering the use of fluoxetine hydrochloride to block serotonin uptake in the brain of animals. Barr argued that this claim was invalid on grounds of obviousness-type double patenting because Lilly’s earlier patent claim in a different patent covered the use of fluoxetine or a pharmaceutically acceptable salt to treat anxiety in humans. The district court denied Barr’s motion for summary judgment. Barr appealed.
Rule of Law
Issue
Holding and Reasoning (Gajarsa, J.)
What to do next…
Here's why 899,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 47,000 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.

